Found: 5
Select item for more details and to access through your institution.
Lack of Drug‐Drug Interaction Between Filgotinib, a Selective JAK1 Inhibitor, and Oral Hormonal Contraceptives Levonorgestrel/Ethinyl Estradiol in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 4, p. 376, doi. 10.1002/cpdd.870
- By:
- Publication type:
- Article
Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.899617
- By:
- Publication type:
- Article
Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus–1.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 11, p. e815, doi. 10.1093/cid/ciaa1534
- By:
- Publication type:
- Article
Pharmacokinetics, Disposition, and Biotransformation of [<sup>14</sup>C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 241, doi. 10.1007/s40262-023-01328-1
- By:
- Publication type:
- Article
The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 599, p. 1, doi. 10.1126/scitranslmed.abg3071
- By:
- Publication type:
- Article